AU8667898A - Use of alpha1a-adrenergic receptor antagonists in glaucoma therapy - Google Patents

Use of alpha1a-adrenergic receptor antagonists in glaucoma therapy

Info

Publication number
AU8667898A
AU8667898A AU86678/98A AU8667898A AU8667898A AU 8667898 A AU8667898 A AU 8667898A AU 86678/98 A AU86678/98 A AU 86678/98A AU 8667898 A AU8667898 A AU 8667898A AU 8667898 A AU8667898 A AU 8667898A
Authority
AU
Australia
Prior art keywords
alpha1a
receptor antagonists
adrenergic receptor
glaucoma therapy
glaucoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU86678/98A
Inventor
Thomas W. Mittag
Steven M. Podos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Publication of AU8667898A publication Critical patent/AU8667898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
AU86678/98A 1997-08-05 1998-07-29 Use of alpha1a-adrenergic receptor antagonists in glaucoma therapy Abandoned AU8667898A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5478197P 1997-08-05 1997-08-05
US60054781 1997-08-05
US7513998A 1998-05-08 1998-05-08
US09075139 1998-05-08
PCT/US1998/015652 WO1999007353A1 (en) 1997-08-05 1998-07-29 USE OF α1A-ADRENERGIC RECEPTOR ANTAGONISTS IN GLAUCOMA THERAPY

Publications (1)

Publication Number Publication Date
AU8667898A true AU8667898A (en) 1999-03-01

Family

ID=26733493

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86678/98A Abandoned AU8667898A (en) 1997-08-05 1998-07-29 Use of alpha1a-adrenergic receptor antagonists in glaucoma therapy

Country Status (2)

Country Link
AU (1) AU8667898A (en)
WO (1) WO1999007353A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6469065B1 (en) 1996-02-02 2002-10-22 Nitromed, Inc. Nitrosated and nitrosylated α-adrenergic receptor antagonist, compositions and methods of use
BR112021007725A2 (en) 2018-10-26 2021-07-27 Ocuphire Pharma, Inc. methods and compositions for treating presbyopia, mydriasis and other ocular disorders
CN115368310A (en) 2021-05-18 2022-11-22 奥库菲尔医药公司 Method for synthesizing phentolamine mesylate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4490379A (en) * 1984-04-04 1984-12-25 Steven Podos Method of reducing intraocular pressure and treating glaucoma using corynanthine
US5086074A (en) * 1988-01-15 1992-02-04 Abbott Laboratories 1-aminomethyl-1,2,3,4-tetrahydronaphthalenes
GB9119467D0 (en) * 1991-09-12 1991-10-23 Smithkline Beecham Corp Chemical compounds
ZA941027B (en) * 1993-02-16 1994-11-11 Smithkline Beecham Corp Chemical compounds

Also Published As

Publication number Publication date
WO1999007353A1 (en) 1999-02-18

Similar Documents

Publication Publication Date Title
AU5274499A (en) Therapeutic chemokine receptor antagonists
AU1403199A (en) Local delivery of therapeutic agents
SG113402A1 (en) Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
AU3102097A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU3659897A (en) Chemokine receptor antagonists and methods of use therefor
AU7692996A (en) Receptor antagonists
ZA98691B (en) Use of central cannabinoid receptor antagonists for the preparation of drugs
AU6535098A (en) Zcytor7 cytokine receptor
AU6721598A (en) Dioxino derivatives and their use as therapeutic agents
AU4846597A (en) Vitronectin receptor antagonists, their preparation and their use
AU9064991A (en) Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
EP1007028A4 (en) 8-iso-prostaglandins for glaucoma therapy
AU4846497A (en) Vitronectin receptor antagonists, their preparation and their use
AU9058591A (en) Use of angiotensin ii receptor antagonists in the treatment of diabetic nephropathy
AU4251197A (en) Therapeutic chemokine antagonists
AU8743098A (en) Benzothiadiazinyl-indole derivatives and their use as serotonin receptor ligands
AU9065291A (en) Use of angiotensin ii receptor antagonists in the treatment of macular degeneration
AU3268197A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU1714599A (en) Treatment of glc1a glaucoma with glucocorticoid antagonists
AU1242800A (en) Isolated vshk-1 receptor polypeptides and methods of use thereof
AU9068398A (en) 3-substituted 3,4,5,7-tetrahydro-pyrrolo3',4':4,5 thieno2,3-dpyrimidine derivatives, their preparation and use as 5ht antagonists
AU8921198A (en) New human g-protein coupled receptor
AU6503900A (en) Chemokine receptor antagonists and methods of use therefor
AU9064191A (en) Use of angiotensin ii receptor antagonists in the treatment of atheroma
AU6035398A (en) Human c5a-like receptor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase